Prophylactic antibiotic trends in transsphenoidal surgery for pituitary lesions.
Pituitary surgery involves operating in the nasal cavity, which is considered a clean-contaminated wound. In the absence of evidence-based guidelines for preventing surgical site infections in trans-sphenoidal surgery, a survey of current opinion on prophylactic antibiotics might help elucidate the current acceptable practices and identify opportunities for prospective clinical trials that could lead to the development of practice guidelines. An on-line, 10-question, multiple-choice survey was distributed by e-mail link to the membership of the International Society of Pituitary Surgeons. Sixty-nine members responded to the survey. Ninety-one percent indicated that there was no strong evidence supporting antibiotic use, but 81% used them to be safe. Ninety percent of respondents used intravenous prophylactic antibiotics, while only 16% used intranasal antibiotics. The most commonly used antibiotics were cephalosporins (72%) and penicillins (21%). Seventy-six percent used antibiotics for 24 h or less after surgery. The most commonly reported indications for prophylactic antibiotics were prevention of meningitis and sinusitis. The results of the survey describe current acceptable practices for chemoprophylaxis in patients undergoing transsphenoidal pituitary surgery.
Little
Andrew S
AS
Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, 350 West Thomas Road, Phoenix, AZ 85013, USA. neuropub@chw.edu
White
William L
WL
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis / Q000379:methods / Q000706:statistics & numerical data / Q000639:trends*; D003625:Data Collection; D013507:Endocrine Surgical Procedures / Q000009:adverse effects / Q000379:methods* / Q000706:statistics & numerical data / Q000639:trends; D006801:Humans; D010900:Pituitary Diseases / Q000453:epidemiology / Q000601:surgery*; D010902:Pituitary Gland / Q000601:surgery*; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data / Q000639:trends; D013100:Sphenoid Bone / Q000601:surgery; D013530:Surgical Wound Infection / Q000453:epidemiology / Q000517:prevention & control*; D011795:Surveys and Questionnaires
D000900:Anti-Bacterial Agents
Cochrane Database Syst Rev. 2004;(3):CD003996
15266512
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007482
20091635
Cochrane Database Syst Rev. 2009 Jan 21;(1):CD001181
19160191
Neurosurgery. 2008 Feb;62 Suppl 2:532-9
18596451
Laryngoscope. 2007 Sep;117(9):1528-32
17667141
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004884
16437502
Neurosurgery. 1997 Feb;40(2):225-36; discussion 236-7
9007854
Br J Neurosurg. 2005 Apr;19(2):155-62
16120519
Surg Neurol. 2007 Aug;68(2):145-8; discussion 148
17537487